Centessa Pharmaceuticals Nets $353M in Nasdaq IPO of ADSs
Asset centric start-up Centessa Pharmaceuticals Ltd. netted $353Med its initial public offering of 19M American Depositary Shares (ADSs; each represents one ordinary share and includes full exercise of the overallotment) at $20 per ADS (the high end of its anticipated $18-20 range) on the Nasdaq Global Market. It originally planned to offer 15M shares. Following the close of the IPO, the company changed its name to Centessa Pharmaceuticals plc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.